By Sahil Pandey July 27 (Reuters) - The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for ...
Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will ...
The FDA approved SimpleScreen CRC, a blood-based screening test for adults 45 years and older who are at average risk for ...
The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...
Freenome Inc. won FDA approval for SimpleScreen CRC, its blood-based colorectal cancer detection test. Freenome Inc., which ...
Health and Me on MSN
US FDA approves new blood test to screen for colorectal cancer
Developed by Freenome, the test is intended for adults aged 45 and older who are at average risk for CRC. It detects ...
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
A Rutgers University study found about half of those who use home-based colon cancer tests fail to retest annually, ...
People who skip colorectal cancer screening because colonoscopy or stool testing seems too burdensome now have a blood test option from Guardant Health among recommendations by the American Cancer ...
After colorectal cancer screening guidelines were updated in 2021 to lower the screening age to 45, three studies look at how ...
Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results